Non-Operative Management of Rectal Cancer with Adjuvant Chemotherapy after Chemoradiotherapy (NORMANDY): Prospective Study [0.03%]
术前同步放化疗加序贯保守治疗或手术的随机对照研究(NORMANDY)
Hyebin Lee,Hyung Ook Kim,Jason Joon Bock Lee et al.
Hyebin Lee et al.
Purpose: Non-operative management (NOM) has emerged as a promising organ-preserving strategy for patients with rectal cancer who achieve a clinical complete response (cCR) after neoadjuvant chemoradiotherapy (CRT). Howeve...
Combined Transarterial Chemoembolization and External Beam Radiotherapy for Identifying Surgical Candidates for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score-Weighted Analysis [0.03%]
结合肝动脉化疗栓塞和外照射治疗识别伴有宏观血管侵犯的 hepatocellular carcinoma 手术候选者的倾向分值权重分析研究
Sumin Lee,Jinhong Jung,Jonggi Choi et al.
Sumin Lee et al.
Purpose: To evaluate the role of hepatic resection in patients with objective responses after combined transarterial chemoembolization (TACE) and radiotherapy (RT) for hepatocellular carcinoma (HCC) with macroscopic vascu...
Malignant Hepatocellular Neoplasm, not Otherwise Specified, Displays Poorer Chemoresponsiveness and Postoperative Prognosis than Hepatoblastoma [0.03%]
未分化的恶性肝细胞瘤与肝母细胞瘤相比化疗反应差，术后预后不良
In Hye Song,Sujin Gang,Hee Mang Yoon et al.
In Hye Song et al.
Purpose: Malignant hepatocellular neoplasm, not otherwise specified (HCN-NOS) is a provisional diagnostic entity, characterised by intermediate or a combination of hepatoblastoma and paediatric hepatocellular carcinoma (p...
Real-world Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer [0.03%]
卡介苗治疗无效的非肌层浸润性膀胱癌患者使用吉西他滨膀胱灌注的疗效分析
Hye Won Lee,Eui Hyun Jung,Kyung Hwan Kim et al.
Hye Won Lee et al.
Purpose: This study aimed to report the real-world outcomes of intravesical gemcitabine for bacillus Calmette-Guérin (BCG) -unresponsive, high-risk, non-muscle-invasive bladder cancer (HR-NMIBC) in Korean patients who we...
Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric and Young Adult Patients with Chronic Myeloid Leukemia in Tyrosine Kinase Inhibitor Era: A Study of the Korean Blood and Marrow Transplantation Registry [0.03%]
酪氨酸激酶抑制剂时代儿童和青年慢性髓性白血病患者同种异体造血干细胞移植的疗效：来自韩国血液和骨髓移植登记处的数据分析
Hee Young Ju,Hyoung Soo Choi,Hyeon Jin Park et al.
Hee Young Ju et al.
Purpose: Chronic myeloid leukemia (CML) in children, adolescents, and young adults is rare and differs from older adults. This study evaluated the outcomes of allogeneic hematopoietic stem cell transplantation (HSCT) in y...
Comparative Study of Mastectomy Using Conventional Techniques, Multiport and Single-Port Robotic Surgical Systems [0.03%]
传统方法、多端口和单端口机器人手术系统的乳房切除术比较研究
Jeea Lee,Jieon Go,Suk Jun Lee et al.
Jeea Lee et al.
Purpose: Oncologic and surgical outcomes of robot-assisted nipple-sparing mastectomy (RNSM) compared to conventional NSM (CNSM) is under investigation. This study compared the clinical outcomes of recurrence-free survival...
Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung Cancer [0.03%]
brigatinib作为起始治疗时序量临床 relevance探讨及ALEX研究事后分析：不同剂量brigatinib的疗效和安全性差异评估
Junkyu Kim,Min-Ji Kim,Jinyong Kim et al.
Junkyu Kim et al.
Purpose: Alectinib has been approved for Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) at 300mg twice daily in Japan, lower than global standard of 600mg twice daily. This study evaluated th...
Adjuvant Chemotherapy in Breast Cancer After Neoadjuvant Therapy: Essential or Optional? [0.03%]
新辅助治疗后的乳腺癌还需要辅助化疗吗？
Di Zhang,Luo Yang,Yuan Zheng et al.
Di Zhang et al.
Purpose: This study aimed to evaluate the impact of postoperative adjuvant chemotherapy (AC) on survival outcomes in breast cancer (BC) patients who have already undergone neoadjuvant chemotherapy (NAC) followed by surger...
IARC Group 1 Pharmaceuticals and Associated Cancer Risks: A Nationwide Population-Based Cohort Study in Korea [0.03%]
韩国全国人群为基础的队列研究中的IARC一组药物及其相关的癌症风险
Woojin Lim,Na Rae Lee,Ho Gyun Shin et al.
Woojin Lim et al.
Purpose: The aim of this study is to summarize cancer risk among patients with clinical indications of immunosuppressive and antineoplastic drugs in Korea, which are pharmaceuticals defined as group 1 by International Age...
Real-World Experience of Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Multiple Myeloma Relapsed/Refractory to Bortezomib and Lenalidomide [0.03%]
卡非佐米联合环磷酰胺和地塞米松治疗对硼替佐米和来那度胺耐药的多发性骨髓瘤患者的真实世界研究
Cheongin Yang,Changgon Kim,Kunye Kwak et al.
Cheongin Yang et al.
Purpose: This retrospective study evaluated the efficacy and safety of a weekly carfilzomib, cyclophosphamide, and dexamethasone (KCd) regimen in patients with relapsed or refractory multiple myeloma (RRMM) who had been p...